Prognostic Implication of a M 6A Regulators Signature in Multiple Myeloma

Jing Wang,Yifan Zuo,Chenglan Lv,Min Zhou,Bing Chen,Yuan Wan

DOI: https://doi.org/10.2139/ssrn.3857598

2021-01-01

Abstract:BackgroundN6-methyladenosine (m6A) regulators play a critical role in tumorigenesis; however, their role in multiple myeloma (MM) remains unknown. This study aimed to create an mRNA prognostic signature based on the m6A regulators status of in patients with MM.Materials and Methods: We integrated data from the Multiple Myeloma Research Foundation CoMMpass Study and the Genotype-Tissue Expression database to analyze gene expression profiles of 21 m6A regulators. Consistent clustering analysis was performed to identify the clusters of patients with MM having different clinical outcomes. Gene distribution was analyzed using principal component analysis. Next, we generated an mRNA gene signature of m6A regulators through a multivariate logistic regression model with least absolute shrinkage and selection operator.Finding: The expressions of m6A regulators, except FMR1, were significantly different in MM samples compared with those in normal samples. The expression levels of KIAA1429, HNRNPC, FTO, and WTAP were significantly downregulated in tumor samples, whereas those of other signatures were remarkably upregulated. Three clusters of patients with MM were identified, and significant differences were found in terms of overall survival (P = 0.024). A prognostic two-gene signature (KIAA1429 and HNRNPA2B1) was constructed, which had a good prognostic significance (area under the receiver operating curve = 0.792). The prognostic signature might be an independent prognostic indicator for patients with MM (P = 0.002).Interpretation: Our findings may improve the understanding of the functional organization of m6A regulators in MM and provide new insights into the treatment for MM patients.'Funding: This work was partially supported by Binghamton University Faculty Startup Fund 910252-35, Binghamton University S3IP award ADLG195.Declaration of Interest: None to declare.